Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer death in many Asian and African countries. Lack of early diagnosis tools is one of the clinical obstacles for effective treatment of HCC. Thus, enhanced understanding of the molecular changes associated with HCC is urgently needed to develo...
Main Authors: | Hui Xie, Hongwei Ma, Danqiu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/136106 |
Similar Items
-
HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma
by: Jun Li, et al.
Published: (2015-09-01) -
Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
by: Qian‐Wen Rao, et al.
Published: (2020-11-01) -
Interference of miR‐107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma
by: Haiming Zhang, et al.
Published: (2020-09-01) -
AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis.
by: Xiaoliang Chen, et al.
Published: (2017-01-01) -
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
by: Danjun Song, et al.
Published: (2020-07-01)